Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  BioPorto A/S    BIOPOR   DK0011048619

BIOPORTO A/S (BIOPOR)

 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
02/14/2017 02/15/2017 02/16/2017 02/17/2017 02/20/2017 Date
2.59(c) 2.49(c) 2.48(c) 2.48(c) 2.52 Last
416 275 897 380 282 403 300 665 34 439 Volume
-1.52% -3.86% -0.40% 0.00% +1.61% Change
More quotes
Company
BioPorto A/S is an in-vitro diagnostics company.It provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies.The company focuses on the diagnosis of obesity, diabetes, primary immune deficiency, and kidney injury.Its products include The NGAL... 
Sector
Pharmaceuticals
Calendar
03/15Earnings Release
More about the company
Latest news on BIOPORTO A/S
02/09 BIOPORTO A/S : Announcement from major shareholder
02/03 BIOPORTO A/S : Siemens cooperation enters into the next phase.
02/02 BIOPORTO A/S : Siemens cooperation enters into the next phase.
01/30 BIOPORTO A/S : completes pre-submission discussions with the FDA
2016 BIOPORTO A/S : expands its NGAL related patent portfolio
2016 BIOPORTO A/S : BioPortos gRAD platform validated for QIAGENs ESEQuant lateral fl..
2016 BIOPORTO A/S : gRAD platform validated for QIAGEN’s ESEQuant lateral flow ..
2016 BIOPORTO A/S : Financial Calendar 2017
2016 BIOPORTO A/S : Share Capital and Votes
2016 BIOPORTO A/S : Completion of rights issue and capital increase
More news
Sector news : Diagnostic & Testing Substances Manufacturers
08:25aDJASTRAZENECA : licenses Cancer Drug Zoladex to TerSera for the US, Canada
02/17DJSHIRE : Files 8K - Other Events
02/17 European shares retreat after week of gains; Allianz rallies after update
02/17 ASTRAZENECA : Top AstraZeneca shareholder Woodford adds to stake, bullish on out..
02/17DJROCHE : U.S. Obtains Records in Lobbyist Probe -- WSJ
More sector news : Diagnostic & Testing Substances Manufacturers
Latest Tweets
01/30BioPorto A/S: BioPorto completes pre-submission discussions with the FDA #Fin.. 
2016BioPorto A/S: BioPorto expands its NGAL related patent portfolio #Finanzierun.. 
2016Nasdaq Copenhagen A/S: BioPorto A/S - admittance to trading and official list.. 
More tweets
Qtime:5
Advertisement
Chart BIOPORTO A/S
Duration : Period :
BioPorto A/S Technical Analysis Chart | BIOPOR | DK0011048619 | 4-Traders
Full-screen chart
Technical analysis trends BIOPORTO A/S
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Managers
NameTitle
Peter Mørch Eriksen CEO & Investor Relations Contact
Thomas Magnussen Chairman
Jan Kuhlmann Andersen Chief Operating Officer
Jakob Brix Christensen Chief Financial Officer
Torben A. Nielsen Vice Chairman
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOPORTO A/S18.10%0
JOHNSON & JOHNSON3.17%323 362
ROCHE HOLDING LTD.4.69%210 814
PFIZER INC.3.51%204 018
NOVARTIS AG3.91%202 998
MERCK & CO., INC.11.08%180 289
More Results